Pfizer Inc (PFE): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Pfizer ( PFE) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 2.0%. By the end of trading, Pfizer rose $0.51 (1.6%) to $31.93 on average volume. Throughout the day, 22,726,775 shares of Pfizer exchanged hands as compared to its average daily volume of 26,426,600 shares. The stock ranged in a price between $31.42-$32.06 after having opened the day at $31.47 as compared to the previous trading day's close of $31.42. Other companies within the Health Care sector that increased today were: Geron Corporation ( GERN), up 39.3%, BG Medicine ( BGMD), up 31.2%, Pernix Therapeutics Holdings ( PTX), up 19.9% and Oculus Innovative ( OCLS), up 18.7%.

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. Its product portfolio includes medicines and vaccines, as well as various consumer healthcare products. Pfizer has a market cap of $199.7 billion and is part of the drugs industry. Shares are up 2.6% year to date as of the close of trading on Monday. Currently there are 8 analysts that rate Pfizer a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, increase in stock price during the past year and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Star Scientific ( STSI), down 10.7%, Oxygen Biotherapeutics ( OXBT), down 8.5%, Oncothyreon ( ONTY), down 8.1% and Natures Sunshine Products ( NATR), down 8.1% , were all laggards within the health care sector with Galena Biopharma ( GALE) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Global Stocks Weaken as Trump Opens New Fronts in Global Trade War

Global Stocks Weaken as Trump Opens New Fronts in Global Trade War

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat